Flu

Edina Avdic, PharmD, MBA, BCPS-AQ ID, discusses 2 investigational influenza treatments for pharmacists to keep an eye on.

Learn about OTC preventions for influenza, handling flu and diabetes, and more.

Edina Avdic, PharmD, MBA, BCPS-AQ ID, discusses her recommendations for treating patients demonstrating resistance to influenza treatments. This video was filmed at the 54th ASHP (American Society of Health-System Pharmacists) Midyear Meeting.

According to a survey commissioned by the American Academy of Family Physicians, certain groups, including millennials and African Americans, are more susceptible to anti-vaccination rhetoric and beliefs, with 51% of Americans reporting they have not received a flu shot this season. In addition, nearly one-third of adults who completed the survey do not plan on getting a flu shot.

Pharmacists play a critical role in protecting patients from seasonal influenza and pneumonia illnesses and sequelae.

Nearly 1 in 3 individuals do not receive vaccinations against influenza, nor do almost 30% of patients with insurance and access to regular medical care, according to findings presented at the American Heart Association Scientific Sessions held November 2019 in Philadelphia, Pennsylvania.

Influenza B has been causing severe illnesses in many areas of the country.

After injecting the flu vaccine into a tumor cell, researchers found that the injection either slowed the growth or shrunk the tumor itself.

Research has been conducted to produce a vaccination that gives patients long-lasting protection from influenza.

Edina Avdic, PharmD, MBA, BCPS-AQ ID, associate director, Antimicrobial Stewardship Program, The Johns Hopkins Hospital in Baltimore, Maryland, discusses current antiviral treatments for influenza. This video was filmed at the ASHP (American Society of Health-System Pharmacists) 54th Clinical Meeting & Exhibition in Las Vegas, Nevada.

The popular prescription influenza antiviral will become more accessible in the United States thanks to Sanofi deal.

Rates of some vaccinations are low in these patients, but pharmacists can play a key role in adherence.

The US Department of Health and Human Services (HHS) has entered an agreement with Sanofi Pasteur to increase the company's domestic pandemic influenza vaccine production capabilities.

Louisiana, Nevada, Texas rank highest in flu activity for the month of November.

Emmes, a scientific research company, will support the development of a universal influenza vaccine that could provide longer-lasting protection than the current vaccines available.

Since 2005, the CDC has enforced National Influenza Vaccination Week to emphasize the importance of continuing flu vaccination even through the winter months. Although it is the holiday season, the CDC and other organizations want to remind the general public that it is never a bad time to get your flu vaccine. Sam Nass, PharmD, MBS and Walgreens Immunizations Manager weighed in on the subject in an interview with Pharmacy Times®.

Knowing patients and their ailments is essential when recommending an OTC cold and cough reliever for short-term use.

Community pharmacy-based immunization services have a proven track record for serving patients.

’Tis the season for cold and flu, as we enter that time of year when patients turn to pharmacists for guidance on self-care products for treating these scourges of winter.

Receiving a flu shot before a heart bypass surgery can stop inflammation throughout the body and possibly lead to a healthier recovery, according to a preliminary study presented at the American Heart Association’s Scientific Sessions in Philadelphia, Pennsylvania.

One health care organization has taken their flu vaccination efforts to the next level, by vaccinating the majority of its 12,000 employees, during a 1-day event called #HitMeWithYourFluShot.

Louisiana and Nevada show the highest flu activity in the first monthly report from the Walgreens Flu Index for October, which shows increased incidence of the flu compared with last year.

According to a study by PMR, the global flu vaccine market is projected to account for a market value of approximately $8 billion by the end of 2029. Increasing vaccination rates and a focus on preventive rather than reactive methods are expected to drive the growth of the market.

Influenza vaccine approved for use in adult patients 65 years and older.

EZC Pak, the first physician formulated, tapered immune support pack, will be presented to millionaire and billionaire investors on ABC’s Shark Tank on Sunday, November 3, at 9 PM ET/8 PM CT.